Lesion Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Lesion clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 192 trials

Recruiting

Top-Down Attentional Control of Visual-Processing

fMRIFocal Brain LesionFocal Lesions
National Institute of Mental Health (NIMH)300 enrolled1 locationNCT01087281
Recruiting
Not Applicable

Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems

Intra-axial TumorsExtra-axial TumorsInfection/Inflammatory Lesions
Hyperfine85 enrolled3 locationsNCT07296263
Recruiting
Not Applicable

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation1,616 enrolled41 locationsNCT06959524
Recruiting
Not Applicable

RGL-305+ Lymphoma + Exploratory Clinical Study

Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
Fudan University12 enrolled1 locationNCT07006012
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi84 enrolled70 locationsNCT06500702
Recruiting
Phase 2

Photo-Acoustic and Ultrasonographic Mammoscope

Malignant Breast TumoursBenign Breast Lesions
Franciscus Gasthuis & Vlietland (Hospital)180 enrolled1 locationNCT07492589
Recruiting
Not Applicable

The Effectiveness of Different Pulse Duration of NMES in Patients With Pyramidal Tract-related Spasticity Measured by Neurophysiological Tools

Pyramidal Tract-related SpasticityUpper Motor Neuron Lesion
University of West Attica45 enrolled1 locationNCT07321158
Recruiting
Not Applicable

Clinical and Radiographic Outcomes of Lesion Sterilization and Tissue Repair Using Zinc Oxide/ 6-gingerol Mix Versus Triple Antibiotic Paste in Non-vital Primary Molars

Clinical OutcomesRadiographic OutcomesLesion Sterilization+6 more
Al-Azhar University60 enrolled1 locationNCT07488416
Recruiting
Not Applicable

TES HT100 Clinical Validation for Brain Injury Screening in Patients With Mild Head Trauma or Neurological Symptoms

Intracranial LesionsMild Traumatic Brain InjuryNeurological Symptoms Not Related to Head Trauma
B&B srl850 enrolled1 locationNCT07490418
Recruiting

Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

Soft Tissue Lesion
Galvanize Therapeutics, Inc.1,000 enrolled8 locationsNCT05851430
Recruiting
Phase 3

Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging Indications

Lesion With Known or Suspected F-choline Uptake
Centre hospitalier de l'Université de Montréal (CHUM)500 enrolled1 locationNCT04999215
Recruiting
Phase 2

Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions

Cervical Lesion
Centre Oscar Lambret85 enrolled1 locationNCT06658405
Recruiting
Not Applicable

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada

Knee Cartilage Lesions
Nanochon, Inc.10 enrolled3 locationsNCT07249489
Recruiting
Not Applicable

Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.

Benign Pancreatic Lesion
Centre Hospitalier Universitaire de Besancon100 enrolled2 locationsNCT06397846
Recruiting

Prospective Registry of Histotripsy for Soft Tissue Tumors

Soft Tissue NeoplasmSoft Tissue CancerSoft Tissue Lesion
University of California, San Francisco200 enrolled1 locationNCT07470008
Recruiting
Not Applicable

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

I) Atypical Squamous Cells of Undetermined Significance (ASC-US)II) Atypical Glandular Cells of Uncertain Significance (AGUS)III) Cervical Intraepithelial Neoplasia (CIN), CIN-1, CIN-2, CIN-3+3 more
Timser SAPI de CV558 enrolled1 locationNCT07480902
Recruiting

A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions

Pancreatic Cystic Lesions
Amplified Sciences Inc50 enrolled3 locationsNCT06894329
Recruiting
Not Applicable

TECTONIC CAD IVL IDE Study

Coronary Artery DiseaseCoronary Artery CalcificationStenotic Coronary Lesion
Abbott Medical Devices335 enrolled41 locationsNCT06885177
Recruiting
Not Applicable

Dynamic Causal Modeling of Neuromodulation of Action Speed Via Targeted TMS-EEG

StrokefNIRSEEG+5 more
Centre Hospitalier Universitaire, Amiens80 enrolled1 locationNCT07468032
Recruiting
Phase 1Phase 2

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more
University of California, San Francisco74 enrolled1 locationNCT05359653